Literature DB >> 11553213

Anatomical basis for the approach and extent of surgical treatment of esophageal cancer.

D Liebermann-Meffert1.   

Abstract

The surgical treatment of cancer of the esophagus includes esophagectomy, adequate radical lymphadenectomy, and esophageal reconstruction. Lymph node metastasis of esophageal cancer is the major factor that influences the prognosis after surgery. Even with an invasion depth limited to the mucosa or submucosa, the prognosis is remarkably poor compared with the same invasion depth in gastric or colorectal cancer. Superficial cancer of the esophagus may metastasize into lymph nodes far distant from the primary tumor, not only into the mediastinum but also into the neck and abdomen. Therefore, these cases require treatment of potentially widely distributed metastases and a safe construction of a viable intestinoesophageal conduit. Under the prevailing conditions, however, surgical interventions without fundamental knowledge of the structures of this area are unacceptable.

Entities:  

Mesh:

Year:  2001        PMID: 11553213     DOI: 10.1046/j.1442-2050.2001.00160.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy.

Authors:  Miguel A Cuesta; Teus J Weijs; Ronald L A W Bleys; Richard van Hillegersberg; Mark I van Berge Henegouwen; Suzanne S Gisbertz; Jelle P Ruurda; Jennifer Straatman; Harushi Osugi; Donald L van der Peet
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

2.  [Esophagectomy as therapeutic principle for squamous cell esophageal cancer].

Authors:  J R Siewert; M Feith; H J Stein
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 3.  [The new TNM classification of tumors of the esophagogastric junction. Surgical consequences].

Authors:  C Schuhmacher; A Novotny; M Feith; H Friess
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

4.  Extended lymphadenectomy in esophageal cancer is debatable.

Authors:  Fernando A M Herbella; Rafael M Laurino Neto; Marco E Allaix; Marco G Patti
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

Review 5.  Lymphatic spreading and lymphadenectomy for esophageal carcinoma.

Authors:  Xiang Ji; Jie Cai; Yao Chen; Long-Qi Chen
Journal:  World J Gastrointest Surg       Date:  2016-01-27

6.  The clinical significance of the intraoperative pathological examination of bilateral recurrent laryngeal nerve lymph nodes using frozen sections in cervical field lymph node dissection of thoracic esophageal squamous cell carcinoma.

Authors:  Jinxin Xu; Bin Zheng; Shuliang Zhang; Taidui Zeng; Hao Chen; Wei Zheng; Chun Chen
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 7.  Undervalued criteria in the evaluation of multimodal trials for upper GI cancers.

Authors:  Björn L D M Brücher; Masaki Kitajima; Jörg Rüdiger Siewert
Journal:  Cancer Invest       Date:  2014-09-24       Impact factor: 2.176

8.  Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma.

Authors:  Peng Qie; Qifan Yin; Xuejiao Xun; Yongbin Song; Shaohui Zhou; Huining Liu; Junpeng Feng; Ziqiang Tian
Journal:  J Cardiothorac Surg       Date:  2021-03-23       Impact factor: 1.637

9.  Calcification score versus arterial stenosis grading: comparison of two CT-based methods for risk assessment of anastomotic leakage after esophagectomy and gastric pull-up.

Authors:  De-Hua Chang; Sebastian Brinkmann; Lucy Smith; Ingrid Becker; Wolfgang Schroeder; Arnulf H Hoelscher; Stefan Haneder; David Maintz; Judith Eva Spiro
Journal:  Ther Clin Risk Manag       Date:  2018-04-17       Impact factor: 2.423

10.  Laparoscopic ischaemic conditioning of the gastric conduit prior to a hybrid mckeown oesophagectomy may not decrease the risk of anastomotic leak.

Authors:  Nader Hanna; Zuhaib M Mir; Erin Williams; Shaila J Merchant; Boris Zevin; Wiley Chung
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-04-20       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.